Chronic pain has a particular kind of loneliness to it. Not because other people can’t see it though that’s part of it but because the treatment system that was supposed to help has often left patients feeling more exhausted than they started. The nerve blocks that worked for three months. The medication that blunted the pain but blunted everything else along with it. The specialist who ran out of ideas and started suggesting the pain might be psychological. The slow, demoralizing accumulation of things that helped a little, then stopped helping, then had to be tapered off.
If you’re living with Complex Regional Pain Syndrome, fibromyalgia, neuropathic pain, or another chronic pain condition in Howard County, and you’ve reached the point where the standard options have been exhausted, ketamine therapy at The Mood Center in Columbia, MD is worth understanding not as a miracle, but as a treatment with a specific and well-studied mechanism that works on pain in a way that most of what you’ve tried before simply doesn’t.
Why Chronic Pain Is So Hard to Treat
Most pain treatments work by targeting the location where pain is being generated blocking nerve signals at the source, reducing inflammation, interrupting transmission pathways at specific points. For acute pain, this approach works well. For chronic pain, particularly pain that has persisted long enough to alter how the central nervous system processes signals, it often doesn’t.
The phenomenon at the root of many treatment-resistant chronic pain conditions is called central sensitization. Over time, persistent pain signals cause the spinal cord and brain to amplify those signals essentially recalibrating the nervous system’s threshold for what registers as pain. Once central sensitization has taken hold, pain can persist independently of the original injury or condition, spread beyond its initial location, and become hypersensitive to stimuli that wouldn’t ordinarily cause discomfort. Standard pain treatments, which address peripheral sources, are not designed to correct this kind of central neurological dysregulation.
This is precisely the problem ketamine is designed to address.
How Ketamine Interrupts the Pain Cycle
Ketamine is a potent antagonist of NMDA receptors specific receptors in the brain and spinal cord that are central to the development and maintenance of central sensitization. By blocking these receptors, ketamine interrupts the amplification cycle that keeps chronic pain self-perpetuating long after the original tissue injury has resolved. For a deeper look at how this mechanism translates into clinical outcomes, the science behind ketamine infusion therapy for chronic pain management covers the research in greater detail.
A 2018 systematic review published in Pain Medicine found that IV ketamine infusions produced significant pain reduction across a range of chronic pain conditions, with effects lasting from weeks to months following a single treatment series a durability that most pharmacological pain treatments don’t achieve. The same review noted that CRPS and neuropathic pain showed particularly strong response profiles.
What’s equally significant is what ketamine doesn’t do. It doesn’t carry the tolerance risk, the respiratory suppression, or the long-term dependency concerns that have made opioid-based pain management increasingly difficult for both patients and physicians to navigate. For Howard County patients who have been managing pain with opioids and want a different path or who have been told opioids aren’t an appropriate long-term option for their condition ketamine offers a mechanistically distinct alternative that addresses the central nervous system involvement that opioids can’t adequately reach.
Conditions That Respond Well to Ketamine Infusions
Complex Regional Pain Syndrome, or CRPS, represents some of the strongest clinical evidence for ketamine’s analgesic effects. CRPS is a chronic pain condition typically affecting a limb following an injury or surgery, characterized by burning pain, swelling, and changes in skin temperature and color that are disproportionate to the original trauma. It involves significant central sensitization, which makes it a condition for which ketamine’s NMDA-blocking mechanism is particularly well suited. Research published in Pain (2019) demonstrated meaningful reductions in pain intensity in CRPS patients receiving IV ketamine, including in cases that had not responded to multiple prior treatment modalities. For those newly diagnosed or still seeking clarity on their diagnosis, understanding the different types of Complex Regional Pain Syndrome can help clarify how the condition presents and why treatment responses vary.
Fibromyalgia characterized by widespread musculoskeletal pain, fatigue, cognitive difficulty, and heightened sensitivity to pressure is another condition where central sensitization plays a central role, and where ketamine’s mechanism aligns well with the underlying pathophysiology. Studies have found that ketamine infusions produce short-to-medium-term reductions in pain and tenderness in fibromyalgia patients, with some patients achieving relief they hadn’t experienced through any other treatment.
Neuropathic pain pain resulting from nerve damage or dysfunction, whether from diabetic peripheral neuropathy, post-herpetic neuralgia, post-surgical nerve injury, or other causes has also shown consistent response to IV ketamine across clinical studies, particularly in patients whose pain hasn’t been adequately controlled with gabapentinoids, SNRIs, or tricyclic antidepressants.
What Treatment Looks Like at The Mood Center in Columbia
Ketamine infusion protocols for chronic pain are structured somewhat differently from those used for depression. Pain protocols often involve longer individual sessions sometimes two to four hours at doses calibrated specifically for analgesia rather than the antidepressant response. The number of infusions in an initial series and the interval between them depends on the specific condition, prior treatment history, and how a patient responds to early sessions.
Every patient at The Mood Center begins with a clinical evaluation to confirm that ketamine is appropriate for their situation and to identify any contraindications or medication interactions that need to be managed. Treatment takes place in private rooms with consistent clinical supervision throughout each session. Vital signs are monitored continuously, and the clinical team is present to support patients through the dissociative state that ketamine produces, which most patients describe as manageable and, in many cases, genuinely restful.
IV ketamine for chronic pain is a self-pay service at The Mood Center, as it is at most ketamine clinics nationwide. Health Savings Accounts and Flexible Spending Accounts can be applied toward treatment costs. The Mood Center’s patient care team is glad to discuss pricing and answer financial questions during a free consultation without any obligation to commit to treatment.
The Depression-Pain Connection
One dimension of chronic pain that often goes unaddressed in pain management settings is its relationship with depression. The two conditions are deeply and neurologically linked chronic pain significantly increases the risk of depression, and depression amplifies pain sensitivity, creating a cycle that each condition makes harder to break. A 2017 analysis published in JAMA Internal Medicine found that patients with both chronic pain and depression had substantially worse outcomes on both fronts than patients with either condition alone, and that addressing the mental health component of chronic pain produced measurable improvements in pain outcomes. Patients navigating this overlap in the broader Maryland area may also find it helpful to read about ketamine therapy options in Annapolis, where similar treatment approaches are available for co-occurring pain and depression.
For patients in Columbia whose chronic pain co-occurs with depression or anxiety, The Mood Center offers SPRAVATO® and TMS both FDA-approved and covered by most major insurance plans as treatments that can address the psychiatric dimension of the picture alongside ketamine infusions for the pain itself. A clinical team that can treat both sides of this equation in the same setting, rather than requiring coordination across separate providers, is meaningfully different from a pain-only or psychiatry-only approach.
Is Ketamine Therapy Right for Your Chronic Pain?
Ketamine isn’t the right fit for every chronic pain patient, and candidacy requires a clinical evaluation. Patients who tend to show the strongest response include those with confirmed central sensitization as a component of their condition, those who haven’t achieved adequate relief from nerve blocks, anticonvulsants, SNRIs, or opioid management, and those with conditions particularly CRPS and fibromyalgia where the clinical evidence for ketamine is most developed.
Patients with uncontrolled hypertension, a history of psychosis, active substance use disorder, or certain cardiovascular conditions may not be appropriate candidates. These are questions the clinical evaluation is designed to answer, and The Mood Center’s team will give you a direct and honest assessment of whether the treatment makes sense for your situation.
Schedule a Free Consultation at The Mood Center Columbia
The Mood Center is located at 11055 Little Patuxent Parkway, Suite 209, Columbia, MD 21044. Our clinical team specializes in ketamine infusion therapy for chronic pain conditions including CRPS, fibromyalgia, and neuropathic pain, and we’re glad to talk through your history and your options before you commit to anything.
Call us at 443-940-MOOD or visit themoodcenter.com/schedule-form to schedule your free consultation.
Elevate Your Mood and reclaim the life that chronic pain has been holding back.
The information in this article is intended for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider to discuss your specific situation and treatment options.
